Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 4, 2025Current Medicinal Chemistry

Bridging Gaps in Long COVID Therapy: A Mini Review

View Full Paper
Ask AI
Bookmark
Share

Authors

WNWassan NoriZHZina Abdullah HusseinRHRoaa Mokram Hamed

Discussion

Loading...

Member takes

Overview

Mini review highlights therapeutic strategies for long COVID, indicating gaps in diagnosis and treatment efficacy.

Key Points

  • Main finding reveals 42% prevalence of long COVID, demonstrating its widespread impact on health.
  • Key evidence points to substantial variations in symptom duration, ranging from 3 months to 2 years.
  • Approach involved a critical analysis of therapeutic strategies, emphasizing both pharmacological and non-pharmacological options.
  • Significance highlights the urgent need for personalized approaches and more rigorous trials to improve patient quality of life.

Cite This Study

Nori et al. (2025) studied this question.

synapsesocial.com/papers/689a0f86e6551bb0af8d090ehttps://doi.org/10.2174/0109298673389691250709181809
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring the psychological impact of long COVID: symptoms, mechanisms, and treatments2025 · 4 citations
  2. 2Insights into Persistent SARS-CoV-2 Reservoirs In Chronic Long-COVID2025 · 3 citations
  3. 3Long-COVID: Current Understanding and Future Directions2025
  4. 4Immunological and non-immunological features specific to Long-COVID: multiple overlapping aetiologies and potential biomarkers2025
  5. 5Long COVID-19: A Concept Analysis2025 · 3 citations